Answers are grounded in this paper and cite their sources.
The use of buprenorphine in pregnancy was associated with a lower risk of adverse neonatal outcomes than methadone use; however, the risk of adverse maternal outcomes was similar among persons who received buprenorphine and those who received methadone. (Funded by the National Institute on Drug Abuse.).
No takes yet. Share an insight, caveat, or question.
Suarez et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: